Pharmaceuticals & Biotechnology • Mid Cap
Lupin Ltd.
₹2,023.40▼ 1.60 (0.08%)
Updated Nov 11, 2026, 3:30PMNOTEData is being fetched with a 2 min delay
Prev. Close₹2,025.00▼ 0.08%
Open₹2,032.60▼ 0.45%
Performance
LowHigh
1,998.102,032.70
52W Low52W High
1,892.902,529.50
Turnover₹184.63 Cr
Volume Traded9.12L
P/E Ratio31.50
Market Cap₹93348.55 Cr
Avg. Volume7.21L
Stories & Reports
Nykaa, Zydus Lifesciences And More Q2 Review: HDFC Sec Sees Up To 83% Upside Across 17 Stocks; Check New Target Prices
Lupin Q2 Review: Jefferies Cuts Target 15%, Flags US Competition; Kotak Retains Add
Lupin Q2 Review: Systematix Revises Target Price, Remains Cautious On US Recovery
Stock Picks Today: Lupin, Dabur, Niva Bupa, Torrent Power, Lenskart, And More On Brokerages' Radar
Q2 Results Highlights: MCX Profit Up 10%; INOX India Revenue Up 27%; NSE Profit Slips 17%; SBI Asset Quality Improves
Buy, Sell Or Hold: L&T, Mahindra & Mahindra, ICICI Bank, Lupin, Siemens Energy And LTM — Ask Profit






V/S
Lupin Ltd.-1.60 (0.08%)NIFTY 50+210.40 (0.84%)
Announcements
Lupin Limited has informed the Exchange about Transcript of Q2 FY2027 Earnings Conference Call.
View Full DocLupin Ltd. Share Price
As of 11 November 2026, Lupin Ltd. share price is ₹2,023.40. The stock opened at ₹2,032.60, compared to its previous close of ₹2,025.00. During today's trading session, Lupin Ltd. share price moved in the range of ₹1,998.10 to ₹2,032.70.
Looking at its last 52-week performance, the stock has touched a low of ₹1,892.90 and a high of ₹2,529.50. On the performance front, Lupin Ltd. share price is up 2.40% on a year-on-year basis.
The market capitalization of Lupin Ltd. is ₹93348.55 Cr, with a P/E ratio of 31.50.
Moving Averages
50 Day(s)
-0.62%2,036.04
100 Day(s)
-8.11%2,201.96
200 Day(s)
-9.54%2,236.90

Join our Official Channels


